AVROBIO (AVRO) Stock Chart & Stock Price History → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free AVRO Stock Alerts $1.25 -0.01 (-0.79%) (As of 05/9/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media AVROBIO Stock Price Performance5 Day Performance+2.46%1 Month Performance-0.79%3 Month Performance-5.30%6 Month Performance-16.11%Year-To-Date Performance-8.09%1 Year Performance+80.38% Receive AVRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AVROBIO and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. AVRO Stock Chart for Friday, May, 10, 2024 AVRO Chart by TradingView AVROBIO Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$1.26$1.25-0.79%$1.27$1.2430,702 shs$56.08 million05/08/2024$1.25$1.26+0.80%$1.26$1.23146,294 shs$56.52 million05/07/2024$1.24$1.25+0.81%$1.27$1.23224,786 shs$56.08 million05/06/2024$1.22$1.24+1.64%$1.25$1.21156,514 shs$55.63 million05/03/2024$1.23$1.22-0.81%$1.24$1.18202,097 shs$54.73 million05/02/2024$1.22$1.23+0.82%$1.25$1.21473,059 shs$55.18 million Get the Latest News and Ratings for AVRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AVROBIO and its competitors with MarketBeat's FREE daily newsletter. 05/01/2024$1.19$1.22+2.52%$1.22$1.17398,885 shs$54.73 million04/30/2024$1.19$1.19$1.22$1.19470,501 shs$53.38 million04/29/2024$1.21$1.19-1.65%$1.21$1.18142,738 shs$53.39 million04/26/2024$1.19$1.21+2.11%$1.22$1.18204,967 shs$54.28 million04/25/2024$1.19$1.19-0.42%$1.20$1.1795,454 shs$53.16 million04/24/2024$1.21$1.19-1.65%$1.21$1.19348,448 shs$53.38 million04/23/2024$1.20$1.21+0.83%$1.23$1.1853,884 shs$54.28 million04/22/2024$1.20$1.20$1.22$1.1852,538 shs$53.83 million04/19/2024$1.24$1.20-3.23%$1.23$1.2039,507 shs$53.83 million04/18/2024$1.22$1.24+1.64%$1.26$1.2236,515 shs$55.63 million04/17/2024$1.26$1.22-3.17%$1.27$1.20203,387 shs$54.73 million04/16/2024$1.26$1.26$1.27$1.24183,989 shs$56.52 million04/15/2024$1.27$1.26-0.79%$1.28$1.24203,318 shs$56.53 million04/12/2024$1.27$1.27$1.29$1.2456,543 shs$56.97 million04/11/2024$1.25$1.27+1.60%$1.29$1.25140,913 shs$56.97 million04/10/2024$1.26$1.25-0.79%$1.27$1.2481,039 shs$56.08 million04/09/2024$1.26$1.26$1.28$1.2492,274 shs$56.52 million04/08/2024$1.27$1.26-0.79%$1.27$1.23107,823 shs$56.52 million04/05/2024$1.31$1.27-3.05%$1.31$1.2683,205 shs$56.97 million04/04/2024$1.30$1.31+0.77%$1.31$1.27160,282 shs$58.77 million04/03/2024$1.28$1.30+1.56%$1.31$1.26155,865 shs$58.32 million04/02/2024$1.28$1.28$1.29$1.22135,543 shs$57.42 million04/01/2024$1.28$1.28$1.30$1.2659,242 shs$57.42 million03/29/2024$1.28$1.28$1.30$1.25104,197 shs$57.42 million03/28/2024$1.26$1.28+1.59%$1.30$1.25104,197 shs$57.42 million03/27/2024$1.26$1.26$1.27$1.22423,615 shs$56.52 million03/26/2024$1.22$1.26+3.28%$1.27$1.2369,151 shs$56.52 million03/25/2024$1.28$1.22-4.69%$1.25$1.15812,323 shs$54.73 million03/22/2024$1.25$1.28+2.40%$1.29$1.2346,202 shs$57.42 million03/21/2024$1.28$1.25-2.34%$1.28$1.2377,122 shs$56.08 million03/20/2024$1.26$1.28+1.59%$1.29$1.24183,970 shs$57.42 million03/19/2024$1.29$1.26-2.33%$1.30$1.2659,161 shs$56.52 million03/18/2024$1.30$1.29-0.77%$1.30$1.27301,725 shs$57.50 million03/15/2024$1.27$1.30+2.36%$1.31$1.20493,518 shs$57.94 millionYou need to know these two things about AI stocks ASAP… (Ad)For 40 years, he's been known as one of the world's most bullish investors. Forbes even referred to him a "perma bull"... But he just shocked the world by issuing a massive bear warning about AI stocks.Go here now for this breaking story.03/14/2024$1.29$1.27-1.55%$1.29$1.25119,358 shs$56.60 million03/13/2024$1.28$1.29+0.78%$1.30$1.25176,659 shs$57.50 million03/12/2024$1.30$1.28-1.54%$1.32$1.27112,495 shs$57.05 million03/11/2024$1.31$1.30-0.76%$1.32$1.26165,003 shs$57.94 million03/08/2024$1.31$1.31$1.33$1.2858,864 shs$58.39 million03/07/2024$1.34$1.31-2.24%$1.34$1.28365,885 shs$58.39 million03/06/2024$1.30$1.34+3.08%$1.34$1.2782,870 shs$59.72 million03/05/2024$1.31$1.30-0.76%$1.33$1.2745,831 shs$57.94 million03/04/2024$1.33$1.31-1.50%$1.35$1.20125,856 shs$58.39 million03/01/2024$1.31$1.33+1.53%$1.36$1.29178,017 shs$59.28 million02/29/2024$1.32$1.31-0.76%$1.33$1.30164,020 shs$58.39 million02/28/2024$1.30$1.32+1.54%$1.33$1.30324,822 shs$58.83 million02/27/2024$1.30$1.30$1.35$1.28261,747 shs$57.94 million02/26/2024$1.28$1.30+1.56%$1.34$1.28270,698 shs$57.94 million02/23/2024$1.29$1.28-0.78%$1.31$1.26115,198 shs$57.05 million02/22/2024$1.30$1.29-0.77%$1.31$1.28128,816 shs$57.50 million02/21/2024$1.30$1.30$1.31$1.28276,910 shs$57.94 million02/20/2024$1.29$1.30+0.78%$1.32$1.28845,960 shs$57.94 million02/19/2024$1.29$1.29$1.32$1.26279,900 shs$57.50 million02/16/2024$1.31$1.29-1.53%$1.32$1.26279,827 shs$57.50 million02/15/2024$1.29$1.31+1.55%$1.31$1.25346,334 shs$58.39 million02/14/2024$1.30$1.29-0.77%$1.30$1.27234,923 shs$57.50 million02/13/2024$1.30$1.30$1.32$1.19697,522 shs$57.94 million02/12/2024$1.32$1.30-1.52%$1.32$1.27472,151 shs$57.94 million02/09/2024$1.30$1.32+1.54%$1.32$1.28231,588 shs$58.83 million02/08/2024$1.32$1.30-1.52%$1.33$1.27140,429 shs$57.94 million Related Companies: Cidara Therapeutics Stock Chart Genenta Science Stock Chart Entera Bio Stock Chart Aligos Therapeutics Stock Chart LENZ Therapeutics Stock Chart Turnstone Biologics Stock Chart Quince Therapeutics Stock Chart OKYO Pharma Stock Chart Ikena Oncology Stock Chart Cyclo Therapeutics Stock Chart Receive AVRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AVROBIO and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVRO) was last updated on 5/10/2024 by MarketBeat.com Staff From Our Partners[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICYou need to know these two things about AI stocks ASAP…InvestorPlaceThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVROBIO, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.